We are live on ! Find out more
MRUS

Merus
MRUS

Delisted

MRUS was delisted on the 29th of December, 2025.

Back to rankings

17 hedge funds and large institutions have $100M invested in Merus in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.97% less ownership

Funds ownership: 39.5% → 32.53% (-7%)

29% less funds holding

Funds holding: 24 → 17 (-7)

35% less capital invested

Capital invested by funds: $155M → $100M (-$54.6M)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
17
Holders Change
-7
Holders Change %
-29.17%
% of All Funds
0%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
3
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IBT
International Biotechnology Trust
United Kingdom
+$1.16M
2
RSCM
Rock Springs Capital Management
Maryland
+$331K
3
UBS Group
UBS Group
Switzerland
+$98.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$4.02K
5
NFA
Nationwide Fund Advisors
Ohio
+$2.2K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$695K
2
Renaissance Technologies
Renaissance Technologies
New York
-$549K
3
SIM
Spark Investment Management
New York
-$458K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$244K
5
Deutsche Bank
Deutsche Bank
Germany
-$174K

MRUS Hedge Fund Activity: Q2 2017 in Review

17 institutional investors reported a position in Merus (MRUS) for Q2 2017, worth a combined $100M — down 35% from $155M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of MRUS and 2 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was International Biotechnology Trust, opening a new position worth an estimated $1.16M. The largest seller was Millennium Management, exiting entirely with an estimated $695K sold.

  • 17 institutional investors held Merus (MRUS) as of Q2 2017, down from 24 in Q1 2017.
  • Funds reported $100M of Merus stock for Q2 2017, down 35% quarter-over-quarter.
  • 2 funds opened new Merus positions in Q2 2017 and 9 closed out, a net change of -7 holders.
  • The largest Merus buyer in Q2 2017 was International Biotechnology Trust, an estimated $1.16M added.
  • The largest Merus seller in Q2 2017 was Millennium Management, an estimated $695K sold.

Based on aggregated 13F filings for Q2 2017.